About this event
Watch our distinguished panel of world-renowned experts reshape the conversation on sensor-based technology!
In this interactive forum, moderated by journalist and TV presenter Stephen Dixon, panelists and the audience will share views on:
Excited? Watch this robust discussion as we rethink treatment limits with sensor-based technology – online now!
This symposium took place at ATTD 2023 on February 23rd in Berlin. After registering, you will receive an email with a link to watch the event on-demand, whenever you have time.
*. mylife™ Loop™ is now authorized to work with Abbott's FreeStyle Libre 3 sensor in Germany. A roll-out to further EMEA countries is planned. Please contact your Local Abbott representative for further information.
This platform is specific for ATTD/2023 International Congress, Abbott products availability may vary by country. Not all features are available in all markets. If you require product information for a specific country, please refer to your local Abbott website.
© 2023 Abbott. All rights reserved. FreeStyle, Libre, and related brand marks are marks of Abbott. Other trademarks are property of their own respective owners.
ADC-67108 v1.0 03/23
Hosted by
Psychological Therapist, Diabetes Center Bad Mergentheim, Research Institute Diabetes-Academy Mergentheim (FIDAM), University Bamberg
Clinical Professor in Primary Care Diabetes and Cardio-metabolic Medicine, Diabetes Research Centre, University of Leicester, Leicester General Hospital
Journalist and TV presenter, living with type 1 diabetes for 31 years
Head of Division of Endocrinology and Diabetology, Department of Medicine II, Medical Center – University of Freiburg, Faculty of Medicine, University of Freiburg
Senior Clinical Lecturer and Honorary Consultant, University of Sheffield, Sheffield Teaching Hospitals
Professor of Metabolic Medicine, Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds and Leeds Teaching Hospitals Trust
Head of Department of Endocrinology and Diabetology, Lariboisière Hospital, Paris, Institut Necker Enfants Malades, INSERM U1151, CNRS UMR 8253, IMMEDIAB Laboratory, Paris
At Abbott, we’re focused on making breakthrough technology accessible and approachable for all. Our sensing technology has revolutionized how people monitor glucose and provides doctors with more data for better informed treatment decisions